Royalty Pharma (RPRX)
NASDAQ: RPRX
· Real-Time Price · USD
36.34
-0.16 (-0.44%)
At close: Aug 15, 2025, 3:59 PM
36.08
-0.72%
After-hours: Aug 15, 2025, 07:21 PM EDT
Royalty Pharma Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 631.91M | 1.09B | 929.03M | 950.05M | 1.76B | 843M | 477.01M | 936.45M | 2.17B | 1.98B | 1.71B | 991.63M | 2.11B | 1.79B | 1.54B | 1.8B | 1.14B | 708.81M |
Short-Term Investments | 13.2M | 728.66M | 841.97M | 48.5M | 38.5M | 29M | 18.3M | 747.46M | 735.01M | 612.52M | 717.04M | 1.23B | 1.29B | 1.12B | 1.26B | 892.51M | 1.51B | 1.66B |
Long-Term Investments | 658.34M | 15.73B | 16.39B | 228.87M | 1.16B | 1.1B | 1.01B | 14.11B | 14.14B | 14.41B | 14.23B | 15.3B | 14.2B | 14.39B | 14.63B | 14.94B | 13.78B | 13.47B |
Other Long-Term Assets | 85.49M | 36.71M | 33.53M | 1.05B | 13.91B | 13.47B | 14.09B | 3.88M | 12.82M | 13.79M | 15.13M | 30.61M | 33.41M | 3.87M | 4.14M | 4.51M | 5.96M | 7.14M |
Receivables | 870.68M | 23.79M | 26.96M | 24.9M | 773.68M | 682.71M | 775.09M | 780.07M | 765.14M | 648.46M | 727.92M | 710.7M | 674.59M | 636.49M | 682.66M | 653.25M | 641.69M | 562.38M |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | 4.45M | 3.08M | 4.19M | 795.64M | 2.29M | 5.01M | 3.8M | 6.78M | 10.22M | 4.57M | 90.52M | 90.52M | 67.12M | 5.39M | 6.63M | 8.95M | 12.1M | 6.66M |
Total Current Assets | 1.52B | 1.84B | 1.8B | 1.79B | 2.58B | 1.56B | 1.27B | 1.73B | 2.95B | 2.63B | 2.55B | 2.34B | 3.5B | 2.98B | 2.88B | 2.78B | 2.71B | 2.42B |
Property-Plant & Equipment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Goodwill & Intangibles | 16.06B | n/a | n/a | 14.97B | 5.32M | n/a | 1.78M | 16.33M | 16.58M | 14.24M | 14.5M | n/a | n/a | n/a | 5.67M | 11.47M | 17.26M | 23M |
Total Long-Term Assets | 16.8B | 15.77B | 16.42B | 16.25B | 15.08B | 14.57B | 15.11B | 14.13B | 14.17B | 14.44B | 14.26B | 15.33B | 14.24B | 14.4B | 14.64B | 14.96B | 13.81B | 13.5B |
Total Assets | 18.32B | 17.61B | 18.22B | 18.04B | 17.66B | 16.13B | 16.38B | 15.86B | 17.12B | 17.07B | 16.81B | 17.67B | 17.74B | 17.38B | 17.52B | 17.73B | 16.51B | 15.91B |
Account Payables | 20.21M | 37.63M | 13.37M | 22.05M | 23.42M | 11.55M | 15.16M | 13.63M | 5.81M | 6.66M | 7.91M | 16.11M | 12.18M | 6.66M | 5.62M | 9.19M | 9.39M | 8.27M |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -5.81M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Short-Term Debt | 999.44M | 998.61M | 997.77M | 996.94M | n/a | n/a | n/a | n/a | 999.37M | 998.44M | 997.51M | 996.58M | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Liabilities | 186.88M | 18.6M | 68.6M | 148.76M | 196.03M | 100.43M | 94.53M | 101.71M | 112.88M | 98.58M | 107.2M | 105.73M | 115.99M | 116.01M | 107.93M | 229.13M | 231.69M | 218.84M |
Total Current Liabilities | 1.21B | 1.18B | 1.25B | 1.17B | 275.7M | 124.57M | 161.38M | 127.93M | 1.17B | 1.12B | 1.17B | 1.13B | 182.33M | 135.87M | 171.25M | 255.06M | 283.99M | 255.98M |
Long-Term Debt | 7B | 6.62B | 6.61B | 6.61B | 7.6B | 6.14B | 6.14B | 6.13B | 6.13B | 6.12B | 6.12B | 6.11B | 7.11B | 7.1B | 7.1B | 7.09B | 5.83B | 5.82B |
Other Long-Term Liabilities | 592.77M | 17.9M | 12.08M | 5.58M | 27.04M | 3.22M | 900K | 11.3M | 8.5M | 12.3M | 2.5M | 9.9M | 43.7M | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Liabilities | 7.61B | 6.64B | 6.63B | 6.62B | 7.63B | 6.14B | 6.14B | 6.14B | 6.14B | 6.14B | 6.12B | 6.12B | 7.15B | 7.1B | 7.1B | 7.09B | 5.83B | 5.82B |
Total Liabilities | 8.82B | 7.82B | 7.88B | 7.78B | 7.9B | 6.27B | 6.3B | 6.27B | 7.31B | 7.25B | 7.29B | 7.26B | 7.33B | 7.24B | 7.27B | 7.35B | 6.11B | 6.08B |
Total Debt | 8.02B | 7.62B | 7.61B | 7.61B | 7.6B | 6.14B | 6.14B | 6.13B | 7.13B | 7.12B | 7.12B | 7.11B | 7.11B | 7.1B | 7.1B | 7.09B | 5.83B | 5.82B |
Common Stock | 44K | 43K | n/a | 45K | 45K | 45K | 45K | 108K | 109K | 108K | 107K | 107K | 107K | 106K | 106K | 106K | 105K | 102K |
Retained Earnings | 2.22B | 2.48B | 2.85B | 2.76B | 2.38B | 2.43B | 2.52B | 2.13B | 2.25B | 2.22B | 1.96B | 2.5B | 2.45B | 2.22B | 2.26B | 2.32B | 2.29B | 1.92B |
Comprehensive Income | 63K | n/a | n/a | n/a | 63K | 63K | 63K | 63K | 63K | 63K | 63K | 16.9M | 13.18M | 12.3M | 16.49M | 20.55M | 28.67M | 29.45M |
Shareholders Equity | 6.35B | 6.69B | 6.95B | 6.87B | 6.48B | 6.5B | 6.53B | 6.14B | 6.28B | 5.95B | 5.63B | 6.15B | 6.03B | 5.78B | 5.78B | 5.79B | 5.73B | 4.88B |
Total Investments | 671.54M | 16.46B | 17.23B | 277.37M | 1.2B | 1.13B | 1.03B | 149.64M | 147.9M | 104.03M | 533.94M | 16.53B | 15.5B | 15.51B | 15.89B | 15.83B | 15.29B | 15.13B |